Bluebird Bio | BLUE - Ordinary Share Capital

Bluebird Bio reported $829K in Ordinary Share Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US USD 71K 0
Alnylam Pharmaceuticals ALNY:US USD 1.24M 10K
Arrowhead Research ARWR:US USD 199K 1000
Biogen BIIB:US USD 100K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bluebird Bio BLUE:US USD 829K 94K
Immunogen IMGN:US USD 2.26M 52K
Intercept Pharmaceuticals ICPT:US USD 42K 1000
IONIS PHARMACEUT IONS:US USD 142K 0
Mirati Therapeutics MRTX:US USD 58K 0
Moderna Inc MRNA:US USD 38.5K 200
Nektar Therapeutics NKTR:US USD 19K 0
Novartis NOVN:VX USD 890M 0
Ptc Therapeutics PTCT:US USD 72K 1000
Sangamo Biosciences SGMO:US USD 1.67M 49K
Sarepta Therapeutics SRPT:US USD 9K 0
Seattle Genetics SGEN:US USD 187K 2K
Ultragenyx Pharmaceutical RARE:US USD 70K 0
YTE INCY:US USD 223K 1000